Skip to content
Home/Companies/MedTech/Seyond

Seyond

MedTech·China·Exited 2025·Held 7yr
Entry
2018
Hold
7yr
Exit
2025

Who owns Seyond?

Seyond is a Chinese MedTech company, formerly owned by Bertelsmann Investments, exited in 2025 (exit via IPO). No current private equity owner is on file.

Hand-verified · updated 2026-07-07

Open JSON · CC-BY
Bertelsmann Investments
Investor
Bertelsmann Investments
Bertelsmann Asia Investments (BAI) · 2008 · VC

Key facts

HQChina
SectorMedTech
StatusAcquired
Exit Type
IPO
Exit Year
2025

More from Bertelsmann Asia Investments (BAI)

Other portfolio companies in the same fund.

SparkView
SparkView
Active
AI/MLChina· 2025
Biren Technology
Biren Technology
Exited 2026
AI/MLChina· 2021
Stori
Stori
Active
FintechMexico· 2020
Deepexi
Exited 2025
AI/MLChina· 2018
NetEase Cloud Music
Exited 2021
TMTChina· 2018
Mobike
Exited 2018
MobilityChina· 2016
to Meituan

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Seyond?

Seyond was formerly owned by Bertelsmann Investments, exited in 2025. No current private equity owner is on file.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue